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Background. Some observational studies have suggested that excess dietary intake of polyunsaturated fatty acids such as linoleic
acid increases cutaneous melanoma risk. We aimed at examining the association between serum fatty acids and melanoma risk
by conducting a population-based case-control study in a northern Italy community. Methods. e percentage composition of
12 fatty acids was determined in 51 newly diagnosed melanoma patients and 51 age- and sex-matched population controls by
extracting total lipids from serum samples using thin layer and gas chromatography. Conditional logistic regression was used to
estimate the relative risk of melanoma associated with tertiles of percentage composition of each fatty acid as well as groupings
including saturated, monounsaturated, and polyunsaturated fatty acids. Results. We found a slightly increased melanoma risk for
stearic and arachidic acids proportion, with and without adjustment for potential confounders. For an n-3 polyunsaturated fatty
acid, docosapentaenoic acid, we found a male-speci�c direct association with melanoma risk. �o other associations emerged for
the other saturated,monounsaturated, and polyunsaturated fatty acids, individually or grouped by type.Conclusions.ese �ndings
do not suggest a major role of fatty acids, including linoleic acid, on risk of cutaneous melanoma, though their evaluation is limited
by the small sample size.
1. Introduction
A steady increase of melanoma incidence rates has been
observed in recent decades inmany countries [1–3]. A report
from England on trends in cancer occurrence in 1991–2000
ranks melanoma incidence as the most rapidly increasing
among all site-speci�c neoplasms, and early detection due to
screening does not appear to be the only explanation of the
growing incidence of the disease [4].
is points to a role of environmental risk factors in
increasing melanoma incidence, but the exact nature of these
factors, apart from ultraviolet exposure, is still unclear [5].
In particular diet, a potentially modi�able risk factor, has
long been suspected to play a role in melanoma occurrence,
though the results of epidemiologic investigations carried out
so far have yielded inconsistent results [6–13]. High intake
of polyunsaturated fatty acids (PUFAs), and of linoleic acid
in particular, have been linked to increased melanoma risk
[6, 10, 14]. In contrast, high intake of fat [15] and of �sh rich
in n-3 fatty acids [12, 16] has been associated with reduced
risk of the disease. Laboratory studies have reported toxic
effects of fatty acids such as linoleic and arachidonic acid on
distinct cell types such as leukemia cells [17], rabbit renal cells
[18], human endothelial cells [19], and murine and human
melanoma cell lines [20], with different potential mecha-
nisms including in vivo isomerization into trans fatty acids
[21]. In epidermal reconstructs, n-6 PUFAs administration
resulted in increased epidermal oxidative damage, possibly
leading to accumulated mutations and increased risk of skin
cancer, especially melanoma [22].
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Taking into account these �ndings and the scarcity of
human studies, in the present investigation we explored the
association between serum fatty acid distribution and the risk
of cutaneous melanoma in a population-based case-control
study.
2. Methods
2.1. Study Population. We invited the patients newly diag-
nosed with cutaneous melanoma attending the Dermato-
logic Clinic of Modena University Hospital in the period
1999–2002 to participate in a population-based case-control
study. Inclusion criteria were residence in Modena Province,
an area in northern Italy with approximately 700,000 inhab-
itants, and a histologically con�rmed diagnosis of cutaneous
melanoma without clinical evidence of metastasis. Fiy-nine
of 84 eligible patients (72.0%) agreed to participate in the
study. We randomly selected a resident of Modena Province,
sex- and age-matched (±5 years) to each patient, from a
database available at the Modena Local Health Authority.
Eligible controls were contacted by telephone and enrolled in
the study aer obtaining their informed consent. e partic-
ipation rate among eligible population controls was 56.3%.
2.2. Data Collection. We asked participants to go, early
morning and fasting, to the Dermatologic Clinic of Modena
where they provided a 10 cc blood sample and completed a
questionnaire on demographic characteristics and lifestyle
habits, including indicators of sun exposure and diet using
the EPIC semiquantitative food frequency questionnaire
[10, 13]. Blood specimens were collected in EDTA tubes,
immediately separated and stored at −20∘C until analysis.
Subjects whose blood samples were separated or stored
more than 24 hours aer collection and whose samples
were not available for other reasons were excluded from
analyses, leaving 51 cases and their matched controls. A
dermatologist determined each participant’s phototype
using the Fitzpatrick phototyping scale [22] and collected
information about family history ofmelanoma, sun exposure,
and other anamnestic characteristics.
2.3. Fatty Acid Determination. We determined serum
fatty acid percentage composition of the following
twelve fatty acids: 16 : 0 (palmitic acid), 17 : 0 (margaric
acid), 18 : 0 (stearic acid), 18 : 1n-9 (oleic acid), 18 : 2n-6
(linoleic acid), 20 : 0 (arachidic acid), 20 : 4n-6 (arachidonic
acid), 20 : 5n-3 (eicosapentaenoic acid, EPA), 22 : 5n-3
(7,10,13,16,19-docosapentaenoic acid, DPA), and 22 : 6n-
3 (4,7,10,13,16,19-docosahexaenoic acid, DHA), 24 : 0
(lignoceric acid), and 24 : 1n-9 (nervonic acid). We also
calculated the serum proportion of the following four
fatty acid categories: SFAs—saturated fatty acids (palmitic
acid, margaric acid, stearic acid, arachidic acid, lignoceric
acid), MUFAs—monounsaturated fatty acids (oleic acid,
nervonic acid); n-6 PUFAs—polyunsaturated fatty acids
(linoleic acid, arachidonic acid); n-3 PUFAs (EPA, DPA,
DHA). Fatty acid proportion was determined in serum
phospholipids by extracting total lipids from serum
samples using thin layer chromatography (TLC) and
T 1: Characteristics of study subjects.
Cases Controls
Characteristic 𝑛𝑛 (%) 𝑛𝑛 (%)
51 (100) 51 (100)
Sex
Male 23 (44.1) 23 (44.1)
Female 28 (54.9) 28 (54.9)
Age
25–49 y 17 (33.3) 16 (31.4)
50–79 y 34 (66.7) 35 (68.6)
Educational attainment level
Elementary school or less 18 (35.3) 17 (33.3)
Middle school 8 (15.7) 8 (15.7)
High school 17 (33.3) 17 (33.3)
College or more 8 (15.7) 9 (17.7)
Phototype
I 3 (5.9) 1 (2.0)
II 25 (49.0) 16 (31.4)
III 21 (41.2) 29 (56.8)
IV 0 (0.0) 5 (9.8)
Missing 2 (3.9) 0 (0)
Sun exposure (days per year)
0 6 (11.8) 3 (5.9)
<15 23 (45.1) 10 (19.6)
15–30 16 (31.4) 27 (52.9)
>30 5 (9.7) 11 (21.6)
Missing 1 (2) 0 (0)
Life-time history of sunburns
0 21 (41.2) 33 (64.7)
1 24 (47.1) 14 (27.5)
2 2 (3.9) 2 (3.9)
>2 2 (3.9) 2 (3.9)
Missing 2 (3.9) 0 (0)
gas-chromatography (GC). Menhaden oil purchased
from Supelco; Bellefonte, PA, and phosphatidylcholine
(LIPOSTABIL vials 250mg/5mL; A. Notterman, Colonia,
Germany; distributed by Aventis-Pharma, Milan) were used
as standards. Total lipids were extracted from serum samples
(400 𝜇𝜇L) with 2mL of chloroform-methanol 2 : 1 (v : v) (35).
Aer centrifugation, the organic layer was transferred into a
tube and evaporated under nitrogen. e dried residue was
dissolved in 60 𝜇𝜇L of chloroform-methanol 2 : 1 (v : v) and
50 𝜇𝜇L of the obtained sample was puri�ed by TLC with a
development mobile-phase composed by A : B (70 : 30 v : v)
where A = chloroform and B = methanol : water : ammonia
93 : 5 : 2 (v : v : v). Phospholipidic fraction was identi�ed
to spray phosphatidylcholine standard with a solution of
phosphomolibdic acid 10% in methanol. Phospholipidic
fraction of samples was extracted, twice, with 2mL of
chloroform-methanol 2 : 1 (v : v), and fatty acid methyl
esters (FAME) of the phospholipidic class were obtained
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T 2: Fatty acid plasma percentage distribution in study subjects.
Systematic name Common name Shortdesignation
Cases Controls




Hexadecanoic Palmitic (16 : 0) 27.70 42.75 26.35 42.75 35.10 36.92
Heptadecanoic Margaric (daturic) (17 : 0) 0.19 3.20 0.01 4.97 0.52 0.64
Octadecanoic Stearic (18 : 0) 11.84 22.41 8.52 21.89 16.53 18.10
Eicosanoic Arachidic (20 : 0) 0.01 1.11 0.01 1.26 0.32 0.47
Tetracosanoic Lignoceric (24 : 0) 0.01 2.25 0.01 1.65 0.72 1.11
MUFAsb
cis-9-octadecenoic Oleic (18 : 1n-9) 9.52 41.69 8.21 38.47 12.72 14.88
cis-15-tetracosenoic Nervonic (24 : 1n-9) 0.01 4.02 0.01 3.52 1.04 1.62
PUFAsb
9,12-octadecadienoic Linoleic (18 : 2n-6) 11.34 23.56 11.32 23.54 17.19 20.07
5,8,11,14-eicosatetraenoic Arachidonic (20 : 4n-6) 0.28 7.41 1.08 6.77 2.75 3.77
5,8,11,14,17-eicosapentaenoic EPA (20 : 5n-3) 0.01 1.44 0.01 2.35 0.14 0.33
7,10,13,16,19-docosapentaenoic DPA (22 : 5n-3) 0.01 0.60 0.01 0.75 0.09 0.18









SFAs 55.95 3.59 55.68 4.12 54.57 56.72
MUFAs + PUFAs 39.29 3.86 39.37 4.18 38.34 40.73
MUFAs 16.27 5.02 16.22 4.99 14.31 16.52
PUFAs 23.02 4.59 23.15 3.60 21.58 25.06
SFAs/MUFAs + PUFAs 1.44 0.21 1.44 0.26 1.35 1.48
SFAs/PUFAs 2.54 0.58 2.47 0.47 2.23 2.61
n-3 PUFAs 1.10 0.60 1.06 0.69 0.71 1.11
n-6 PUFAs 21.92 4.33 22.09 3.40 20.53 24.04
n-3 PUFAs/n-6 PUFAs 0.05 0.02 0.05 0.03 0.03 0.05
a
Percentile cutpoints based on fatty acid distribution in controls.
bSFAs: saturated fatty acids; MUFAs: monounsaturated fatty acids; PUFAs: polyunsaturated fatty acids.
through transesteri�cation with 2mL of hydrochloric acid in
methanol (3N) (Supelco, Bellefonte, PA). FAMEwere further
extracted into 1mL of hexane and 0.5 𝜇𝜇L of the mixture was
injected for gas-chromatographic measurement.
e GC analysis was performed using an 8610 DANI
instrument (Monza, Italy) equipped with a temperature
vaporizer injector and a �ame ionization detector. We
introduced the samples into the capillary column using a
split-splitless technique, using a BPX70 column (30m ×
0.25mm i.d.) with 0.25 𝜇𝜇m �lm thickness purchased from
SGE (Ringwood, Australia). e gas conditions were: carrier
gas helium at �ow rate of 0.8mL/min; hydrogen 0.5mL/min;
make-up gas nitrogen 0.5mL/min. e oven temperature
increased from 130∘C to 210∘C at a rate of 3∘C/min, from
210∘C to 260∘C at a rate of 5∘C/min, then kept constant
for 3 minutes. Identi�cation of FAME was obtained by
comparison with the relative retention times of a commercial
standard solution (Menhaden oil). e chromatograms were
recorded and processed by computer-aided methods. e
relative amount of each FAME (percent of total area) was
quanti�ed by integrating the peak and dividing the results
by total area for all fatty acids identi�ed. e detection
limit was 0.01% for all fatty acids. Within-day coefficients
of variation (CV) were based on the analysis of the same
serum sample, extracted and analyzed 10 times during the
same day. CV ranged from 0.6% for large peaks to 38.6%
for small peaks. e between-day CVs were based on the
analysis of one serum sample on separate days (up to 19
days). CV for all fatty acids were: 5.20% for palmitic, 28.15%
for margaric, 6.20% for stearic, 69.31% for arachidic, 39.12%
for lignoceric, 7.65% for oleic, 47.21% for nervonic, 6.55%
for linoleic, 9.82% for arachidonic, 23.01% for EPA, 24.31%
for DPA, 18.89% for DHA. Serum samples were analysed in
19 consecutive cycles; for every cycle we added a standard
(cod liver oil) and a quality control serum sample. Data
were expressed as percentage of each fatty acid calculated
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T 3: Odds ratio (OR) with 95% con�dence intervals (CI) of melanoma by tertile of serum fatty acid percentage composition.
Ia II III
𝑃𝑃 trendOR OR (95% CI) OR (95% CI)
SFAsb
Palmitic 1.00 1.00 (0.37–2.71) 0.75 (0.23–2.41) 0.568
Margaric (daturic) 1.00 0.85 (0.30–2.47) 1.29 (0.40–4.21) 0.783
Stearic 1.00 1.48 (0.50–4.42) 1.94 (0.61–6.20) 0.115
Arachidic 1.00 1.76 (0.44–7.02) 2.13 (0.61–7.46) 0.400
Lignoceric 1.00 0.69 (0.24–1.99) 0.57 (0.18–1.77) 0.725
MUFAsb
Oleic 1.00 1.02 (0.42–2.46) 1.23 (0.44–3.45) 0.909
Nervonic 1.00 1.79 (0.51–6.24) 1.59 (0.32–7.94) 0.876
PUFAsb
Linoleic 1.00 0.73 (0.27–1.98) 0.77 (0.28–2.15) 0.406
Arachidonic 1.00 0.57 (0.21–1.55) 1.33 (0.53–3.33) 0.402
EPA 1.00 2.17 (0.68–6.90) 1.16 (0.30–4.43) 0.600
DPA 1.00 1.2 (0.44–3.24) 1.00 (0.34–2.91) 1.000
DHA 1.00 0.65 (0.22–1.90) 0.67 (0.24–1.86) 0.891
Groupings
SFAs 1.00 0.41 (0.11–1.48) 1.65 (0.49–5.51) 0.589
MUFAs + PUFAs 1.00 0.81 (0.31–2.16) 0.76 (0.23–2.55) 0.884
MUFAs 1.00 0.95 (0.35–2.59) 1.08 (0.36–3.24) 0.932
PUFAs 1.00 0.57 (0.20–1.64) 0.78 (0.27–2.21) 0.859
SFAs/MUFAs + PUFAs 1.00 1.03 (0.33–3.25) 1.25 (0.41–3.81) 0.907
SFAs/PUFAs 1.00 0.71 (0.26–1.95) 1.33 (0.50–3.46) 0.478
n-3 PUFAs 1.00 0.82 (0.24–2.71) 1.11 (0.37–3.36) 0.718
n-6 PUFAs 1.00 0.61 (0.21–1.74) 0.90 (0.33–2.47) 0.807
n-3 PUFAs/n-6 PUFAs 1.00 1.99 (0.73–5.26) 1.31 (0.42–4.02) 0.679
a
Referent group.
bSFAs: saturated fatty acids; MUFAs: monounsaturated fatty acids; PUFAs: polyunsaturated fatty acids.
on the total amount of fatty acids separated from the seric
phospholipidic fraction. Determinations below the detection
limit (0.01%) were assigned a value of 0.01%.
2.4. Statistical Analysis. We computed odds ratios (OR) as an
estimate of relative risk according to categories of fatty acid
serum levels, based on a matched analysis using conditional
logistic regression. For these analyses, levels of serum fatty
acids were categorized into tertiles based on the distribution
in controls, using the bottom tertile as the reference group.
We also tested for linear trend by entering fatty acid compo-
sition as continuous variable. We repeated analyses adjusting
for phototype, sun exposure, and education in multivariate
analysis, and conducted sex- and age- (≥50 versus <50 years)
strati�ed analyses.We also comparedmean dietary intakes of
selected fatty acids and fatty acids categories using Student’s
t-test.
3. Results
Demographic and clinical characteristics of cases and con-
trols are reported in Table 1. Cases were similar to controls
on educational attainment, had somewhat lower phototypes,
and reported a higher occurrence of sunburns than controls.
Table 2 summarizes the fatty acid distribution in sera of
study participants, and Table 3 reports the ORs for cutaneous
melanoma according to percentage composition of each
serum fatty acid in unadjusted analyses. e proportions
of stearic and arachidic acid were directly associated with
increased melanoma risk, though these associations were
limited and statistically imprecise. Compared with the low-
est tertile, ORs for the highest tertile were 1.94 (95% CI,
0.61–6.20; P trend = 0.115) for stearic acid and 2.13 (95%
CI, 0.61–7.46; P trend = 0.400) for arachidic acid. However,
no association was detected for the overall SFAs group. No
association was found with any of the other unsaturated fatty
acids or with their groupings, nor with the ratios between the
fatty acid categories.
We also compared cases and controls with respect to
distribution of dietary intakes of the fatty acids which could
be estimated with the EPIC food frequency questionnaire
(saturated fatty acids, monounsaturated and polyunsaturated
fatty acids, oleic, linoleic and linolenic acid). Mean intakes
were similar in the two groups, with the exception of a
somewhat higher linoleic acid intake in cases (8.48 g/day)
compared with controls (7.75 g/day, P = 0.242).
ORs adjusted for educational attainment, skin phototype,
and sun exposure are shown in Table 4. An increased risk of
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T 4: Odds ratio (OR) with 95% con�dence intervals (CI) of melanoma by tertile of serum fatty acids percentage composition, adjusted
for phototype, education and sun exposure.
Ia II III
𝑃𝑃 trendOR OR (95% CI) OR (95% CI)
SFAsb
Palmitic 1.00 0.79 (0.22–2.87) 0.71 (0.18–2.76) 0.440
Margaric (daturic) 1.00 0.49 (0.12–1.91) 1.66 (0.39–7.16) 0.646
Stearic 1.00 1.85 (0.46–7.43) 3.00 (0.56–16.07) 0.101
Arachidic 1.00 1.13 (0.20–6.54) 2.05 (0.45–9.40) 0.334
Lignoceric 1.00 0.24 (0.05–1.11) 0.38 (0.09–1.55) 0.552
MUFAsb
Oleic 1.00 1.98 (0.51–7.60) 0.82 (0.22–3.08) 0.977
Nervonic 1.00 1.82 (0.31–10.78) 1.26 (0.15–10.48) 0.305
PUFAsb
Linoleic 1.00 1.10 (0.34–3.58) 0.71 (0.20–2.45) 0.420
Arachidonic 1.00 0.50 (0.14–1.86) 1.10 (0.33–3.71) 0.459
EPA 1.00 1.65 (0.40–6.69) 0.64 (0.12–3.40) 0.785
DPA 1.00 0.49 (0.13–1.85) 0.73 (0.20–2.67) 0.697
DHA 1.00 0.42 (0.09–2.00) 0.44 (0.11–1.74) 0.581
Groupings
SFAs 1.00 0.28 (0.04–1.73) 1.56 (0.37–6.61) 0.848
MUFAs + PUFAs 1.00 0.62 (0.17–2.26) 0.52 (0.11–2.34) 0.686
MUFAs 1.00 1.33 (0.33–5.29) 0.71 (0.17–2.96) 0.876
PUFAs 1.00 0.95 (0.25–3.59) 0.98 (0.28–3.46) 0.850
SFAs/MUFAs + PUFAs 1.00 1.41 (0.33–6.05) 1.65 (0.43–6.33) 0.962
SFAs/PUFAs 1.00 0.88 (0.25–3.12) 1.31 (0.41–4.14) 0.692
n-3 PUFAs 1.00 0.70 (0.16–3.08) 0.95 (0.23–3.93) 0.531
n-6 PUFAs 1.00 0.64 (0.17–2.46) 0.97 (0.29–3.17) 0.775
n-3 PUFAs/n-6 PUFAs 1.00 1.55 (0.46–5.27) 1.04 (0.25–4.37) 0.504
a
Referent group.
bSFAs: saturated fatty acids; MUFAs: monounsaturated fatty acids; PUFAs: polyunsaturated fatty acids.
melanoma was con�rmed for stearic acid (OR for the highest
tertile 3.00, 95%CI 0.56–16.07, P trend 0.101) and arachidic
acid (OR for the highest tertile 2.05, 95% CI 0.45–9.40, P
trend 0.334). Aweak and statistically very unstable indication
of an inverse association betweenmelanoma risk and linoleic
fatty acid also emerged (OR for the highest tertile 0.71,
95% CI 0.20–2.45, P trend 0.420). We performed a further
multivariate analysis also adjusting for estimated dietary
intakes of vitamin D, fruit and vegetables: none of these
variables substantially modi�ed the results.
When we strati�ed on sex and age, there was little
indication of any interaction with these factors. e only
notable �nding was for the sex-speci�c analysis for docos-
apentaenoic acid, for which we observed a strong male-
speci�c positive association with melanoma risk (OR 32.24
for the highest tertile, 95%CI 1.68–616.34,P trend 0.029), that
was con�rmed in multivariate analysis.
4. Discussion
A direct relation between melanoma risk and dietary intake
of fatty acids, particularly PUFAs, has been observed or
suggested in some studies [6, 10, 14, 23], though other
epidemiologic investigations did not detect this association
[24–27] or found an inverse association [16]. However, only
one study on this topic using biomarkers (percentage of fatty
acids in subcutaneous adipose tissue) has been performed to
date [14], to the best of our knowledge, and therefore the
present one appears to be the �rst study on fatty acids as a
risk factor for melanoma analyzing serum distribution rather
than assessing their dietary intakes from food questionnaires.
We found positive associations between melanoma inci-
dence and serum proportions of stearic and arachidic acid.
is �nding has some consistencies with the results of the
case-control study by Millen et al. [9], who reported an
increasedmelanoma risk for higher intakes of saturated fat. In
contrast, our previous studies based on assessment of dietary
intake did not suggest such association [10, 13]. For PUFAs
and linoleic acid, in the present investigation we observed no
association and a weak inverse association with risk, respec-
tively, in contrast with our previous observations in this study
population of an increased melanoma risk associated with n-
6 PUFAs levels and with linoleic acid itself [10, 13], and with
the excess melanoma risk among high consumers of cod liver
oil, a supplement rich in n-3 PUFA, in a Norwegian cohort
[6]. In sex-speci�c analyses, the n-3 PUFA docosapentaenoic
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acid was positively associated with melanoma risk in males,
a result inconsistent with the observation by Veierod et
al. of an increased melanoma risk associated with use of
PUFA intake in females and not in males [6]. We speculate
that the inconsistencies of the results between investigations
based on dietary intake and the present study might be
due to methodological issues such as the different indicator
of fatty acid intake adopted (dietary intake of fatty acids
instead of serum levels/percentage composition as in the
present investigation), or by uncontrolled confounding. e
inconsistencies may also be due to chance.
Strengths of the present study include its population-
based design, which reduces the risk of selection bias com-
pared with hospital-based studies [28], and the adjustment
for potential confounders, such as phototype, education, and
sun exposure, known or suspected to in�uence melanoma
risk. is study also has important limitations: its small sam-
ple size, which led to low statistical precision and hampered
the detection of possible minor effects on risk; the possibility
of residual confounding; and the use of percentage compo-
sition of serum fatty acids instead of their absolute levels,
an approach which might have hidden some associations
compared with an analysis based on serum concentrations
of the fatty acids. In addition, the fatty acid assays were
conducted postdiagnosis, and may not re�ect the relevant
prediagnosis composition.
In conclusion, taken as a whole, this study yielded little
evidence of an association between melanoma risk and
circulating fatty acids. However, there was limited evidence
for a direct relation between melanoma risk and stearic and
arachidic acids, and docosapentaenoic acid in males, which
may be worth further investigation.
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